Digital Therapeutics: Challenges Developing & Commercializing DTX Innovations
Transforming a great idea into a Digital Therapeutics (DTx) app that works in healthcare’s complex ecosystem can be painstakingly difficult.
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Transforming a great idea into a Digital Therapeutics (DTx) app that works in healthcare’s complex ecosystem can be painstakingly difficult.
The role of alcohol in dementia risk still warrants further research on its effects on brain health and better patient education.
Overall response rate (ORR) of 71% (95% confidence interval [CI] 51—87) among those with all types of thyroid cancers (n=28), 86% (95% CI 64—97) among patients with differentiated thyroid cancer (DTC; n=22) and 29% (95% CI 4—71) among patients with anaplastic thyroid cancer (ATC; n=7)1Overall median time to response...
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA)...
Pfizer Inc. announced today that the European Commission has approved XELJANZ ® for the treatment of active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis in patients two years of age and older who have responded inadequately to previous therapy with disease modifying antirheumatic drugs . Two formulations were approved, a tablet and a new oral solution . XELJANZ is the first and only ...